Safety and Tolerability of a Novel Peptide-Based Immunotherapy for Peanut Allergy
The journal of allergy and clinical immunology/Journal of allergy and clinical immunology/The journal of allergy and clinical immunology（2019）
摘要
Peanut allergy is a life-threatening condition for which there is currently no cure. Immunotherapy using whole peanut preparations is hindered by risk of causing severe allergic reactions during treatment. PVX108 is a peptide-based immunotherapy being developed to treat peanut allergy without triggering allergic reactions during treatment.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要